Insider Transactions in Q2 2025 at Heron Therapeutics, Inc. (HRTX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2025
|
Ira Duarte EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+7.76%
|
-
|
|
Jun 06
2025
|
William P Forbes EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+8.47%
|
-
|
|
Apr 30
2025
|
William P Forbes EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,694
+8.71%
|
-
|
|
Apr 30
2025
|
Ira Duarte EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,694
+7.91%
|
-
|
|
Apr 30
2025
|
Craig A Collard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34,789
+7.55%
|
-
|
|
Apr 19
2025
|
William P Forbes EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,875
+3.38%
|
-
|
|
Apr 19
2025
|
Ira Duarte EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,875
+3.02%
|
-
|
|
Apr 19
2025
|
Craig A Collard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,796
+3.41%
|
-
|
|
Apr 03
2025
|
Craig A Collard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+14.21%
|
-
|